{"id":8241,"date":"2025-11-12T13:25:39","date_gmt":"2025-11-12T13:25:39","guid":{"rendered":"https:\/\/echonews.fr\/?page_id=8241"},"modified":"2025-11-12T13:50:47","modified_gmt":"2025-11-12T13:50:47","slug":"evolution-variation-and-pathology-the-dual-role-of-structural-variants-in-human-genomes","status":"publish","type":"page","link":"http:\/\/echonews.fr\/?page_id=8241","title":{"rendered":"Evolution-Variation-and Pathology-The Dual Role of Structural Variants in Human Genomes"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Bibliographic and Educational Resources in Cytogenomics<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

This platform is designed to serve as a comprehensive educational and bibliographic resource for healthcare professionals involved in cytogenomics.<\/span><\/strong> Covering a wide range of up-to-date topics within the field, it offers structured access to recent scientific literature and a variety of pedagogical tools tailored to clinicians, educators, and trainees.<\/p>

Each topic is grounded in a curated selection of recent publications, accompanied by in-depth summaries that go far beyond traditional abstracts<\/strong><\/span>\u2014offering clear, clinically relevant insights without the time burden of reading full articles. These summaries act as gateways to the original literature, helping users identify which articles warrant deeper exploration.<\/p>

In addition to these detailed reviews, users will find a rich library of supplementary materials<\/span><\/strong>: topic overviews, FAQs, glossaries, synthesis sheets, thematic podcasts, fully structured course outlines adaptable for teaching, and ready-to-use PowerPoint slide decks. All resources are open access and formatted for easy integration into academic or clinical training programs.<\/p>

By providing practical, well-structured content, the platform enables members of the cytogenomics community to efficiently update their knowledge on selected topics. It also offers educational materials that are easily adaptable for instructional use.<\/span><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Evolution, Variation, and Pathology: The Dual Role of Structural Variants in Human Genomes<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr C\u00e9cile Dupont<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\tHm-envelop<\/span>\n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\tLinkedin<\/span>\n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Pierre durand<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\tHm-envelop<\/span>\n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\tYoutube<\/span>\n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\tLinkedin<\/span>\n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tOVERVIEW<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t1. Evolution, Variation, and Pathology: The Dual Role of Structural Variants in Human Genomes<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Structural variants (SVs)\u2014large-scale genomic alterations that include deletions, duplications, insertions, inversions, and translocations\u2014represent one of the most dynamic and consequential forms of genetic variation in humans. Far from being rare genomic accidents, they are integral to genome evolution, a major source of inter-individual diversity, and a frequent cause of genetic disease. Recent advances in next-generation sequencing, high-resolution cytogenetics, and chromosome conformation mapping have profoundly changed how cytogeneticists understand the impact of SVs, revealing that the same mechanisms driving genomic innovation can also generate pathogenic rearrangements. The dual role of structural variation\u2014fueling evolutionary change while predisposing to disease\u2014illustrates the delicate balance between genome plasticity and stability that underlies human biology.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2. The Nature and Formation of Structural Variants<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

SVs are defined as genomic alterations typically larger than 50 base pairs, encompassing copy number variants (CNVs, including deletions and duplications), inversions, insertions, and more complex rearrangements. Unlike single-nucleotide polymorphisms, SVs disrupt the continuity of the DNA double helix, often involving thousands to millions of base pairs. Their formation is intimately linked to the architectural features of the genome\u2014especially low-copy repeats (LCRs), segmental duplications, and repetitive elements such as Alu<\/em> and LINE sequences\u2014that provide homologous substrates for aberrant recombination.<\/p>

As described by Carvalho and Lupski (2016), two main mechanistic classes underlie SV formation. Recombination-based mechanisms<\/strong>, particularly non-allelic homologous recombination (NAHR), occur when misaligned repeats engage in crossover during meiosis or mitosis, generating recurrent deletions and duplications of predictable size and breakpoint location. By contrast, replication-based mechanisms<\/strong>, such as Fork Stalling and Template Switching (FoSTeS) and Microhomology-Mediated Break-Induced Replication (MMBIR), involve errors during DNA synthesis and repair, producing complex, nonrecurrent rearrangements often accompanied by microhomology at junctions. Non-homologous end joining (NHEJ) further contributes to this diversity through blunt-end or microhomology-mediated DNA repair. These molecular pathways, though essential for genomic maintenance, inadvertently create the substrates for both genomic diversity and disease.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t3. Structural Variants as Engines of Evolutionary Innovation<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

From an evolutionary perspective, SVs are not merely sources of instability but key drivers of genome evolution and species divergence. Copy number variation\u2014segments of DNA present in variable copy numbers across individuals\u2014can alter gene dosage, create novel gene combinations, and facilitate adaptive traits. Studies like those reviewed by Gamazon and Stranger (2015) emphasize that CNVs contribute substantially to human phenotypic diversity and adaptation. For instance, variation in the AMY1<\/em> gene, encoding salivary amylase, correlates with dietary starch intake across human populations, demonstrating how CNV-mediated dosage changes can confer selective advantages.<\/p>

Duplications provide raw material for gene innovation<\/strong>. Initially redundant copies can accumulate mutations, giving rise to new gene functions (neofunctionalization) or partitioning of ancestral functions (subfunctionalization). Newman et al. (2015) revealed that most duplication CNVs are tandem and in direct orientation, a configuration that facilitates gene copy expansion without disrupting regulatory context. Yet, some duplications result in fusion genes at breakpoints\u2014novel chimeric sequences that can either drive evolutionary novelty or cause disease. The same processes that produced beneficial gene families, such as those for olfactory receptors or immune system components, can also underlie deleterious rearrangements associated with developmental disorders.<\/p>

Moreover, the large-scale organization of the genome into topologically associating domains (TADs)<\/strong> provides an additional evolutionary layer. As Lupi\u00e1\u00f1ez et al. (2015) demonstrated, these chromatin domains delineate regions within which genes and their enhancers interact. TAD boundaries, typically enriched in CTCF and cohesin, appear remarkably conserved across species, suggesting strong evolutionary constraints. Alterations of TAD structure can create novel enhancer-promoter interactions, potentially driving morphological diversification during evolution. However, the same rearrangements that might contribute to evolutionary innovation can also disrupt normal gene regulation, leading to congenital malformations. Thus, genome topology functions as both a scaffold for evolutionary flexibility and a safeguard against pathological misexpression.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t4. Structural Variation as a Source of Pathology<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

While SVs can be beneficial or neutral, they are also a major cause of human disease. Clinical cytogenetics increasingly recognizes SVs as responsible for a substantial proportion of congenital anomalies, neurodevelopmental disorders, and cancers. Pathogenic effects arise through several mechanisms: gene dosage imbalance, gene disruption, position effects altering regulatory context, or the creation of fusion genes.<\/p>

In deletions, haploinsufficiency results when a single remaining allele cannot produce adequate gene product. Duplications can lead to triplosensitivity, where excess gene dosage perturbs normal cellular pathways. As Newman et al. detailed, complex duplication events can also generate in-frame gene fusions, creating aberrant proteins with altered or novel functions. Such rearrangements are hallmarks of oncogenesis but are increasingly recognized in congenital disease.<\/p>

Beyond dosage effects, SVs can exert regulatory pathologies<\/strong> through disruption of chromatin architecture. The work of Lupi\u00e1\u00f1ez et al. revealed that rearrangements crossing TAD boundaries can \u201crewire\u201d enhancer\u2013promoter interactions. In limb malformations such as F-syndrome and brachydactyly, duplications or deletions near the EPHA4<\/em> locus reposition limb-specific enhancers, causing ectopic activation of neighboring genes like PAX3<\/em> or IHH<\/em>. This \u201cenhancer hijacking\u201d illustrates how structural rearrangements confined to noncoding DNA can have profound developmental consequences. It also underscores a major paradigm shift in cytogenetics: pathogenicity cannot be predicted solely by coding sequence content but must consider 3D genome organization.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t5. The Continuum Between Evolutionary Adaptation and Disease<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

A unifying insight from these studies is that the line separating adaptive and pathological variation is remarkably thin. The same molecular mechanisms\u2014NAHR, replication-based template switching, and chromatin domain reorganization\u2014that promote genetic diversity are also responsible for disease-causing mutations. This evolutionary\u2013pathological continuum reflects the inherent trade-off between genome flexibility and stability.<\/p>

Genomic regions that facilitate rapid structural innovation, such as those rich in segmental duplications or repetitive elements, are simultaneously \u201cfragile sites\u201d prone to deleterious rearrangements. For example, loci associated with Charcot\u2013Marie\u2013Tooth disease type 1A and its reciprocal deletion syndrome, hereditary neuropathy with liability to pressure palsies, are both mediated by NAHR between the same flanking repeats. Such loci exemplify the \u201ctwo-edged sword\u201d of genomic architecture: repeats that enable adaptive copy number expansion also predispose to recurrent disease-causing rearrangements.<\/p>

Similarly, the functional redundancy introduced by gene duplication can mask deleterious effects in the short term, allowing variants to persist in populations and potentially contribute to adaptation. However, under different environmental or developmental contexts, these same CNVs can become pathogenic. The UGT2B17<\/em> deletion, for instance, influences steroid metabolism and drug response but has also been implicated in osteoporosis and graft-versus-host disease, highlighting how the same structural variant can have pleiotropic outcomes depending on tissue context and environmental interactions.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t6. Cytogenetic and Genomic Perspectives: Mapping and Interpreting Structural Variation<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Modern cytogenetics has evolved from karyotyping to a multi-scale, integrative discipline combining molecular, genomic, and 3D chromatin approaches. The studies discussed collectively illustrate the necessity of such integration. High-resolution array CGH and SNP arrays provide quantitative assessments of CNVs, while next-generation and whole-genome sequencing, as applied by Newman et al., enable nucleotide-level resolution of breakpoints. FISH and long-range PCR remain indispensable for validating complex rearrangements.<\/p>

Equally transformative has been the inclusion of chromatin conformation capture technologies<\/strong>\u2014such as Hi-C and 4C-seq\u2014exemplified by Lupi\u00e1\u00f1ez et al. These techniques reveal how structural variants reshape higher-order genomic topology, offering a bridge between classical cytogenetics and functional genomics. Integrating such data with transcriptomic analyses (Gamazon & Stranger) enables researchers to link structural variation directly to expression quantitative trait loci (eQTLs) and clinical phenotypes, ultimately supporting personalized genomic medicine.<\/p>

This convergence of cytogenetic visualization, molecular sequencing, and 3D architecture mapping defines a new era of integrative cytogenomics<\/strong>, where the interpretation of SVs extends beyond the linear genome to encompass its spatial and functional dimensions.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t7. Conclusion<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Structural variants embody the paradox of genomic evolution: they are simultaneously architects of diversity and agents of disease. Through recombination and replication-based mechanisms, the human genome continuously reshapes itself, generating CNVs, inversions, and translocations that contribute to both adaptability and pathology. As shown across the four foundational studies, the impact of SVs is multifaceted\u2014affecting gene dosage, regulatory networks, and chromatin architecture.<\/p>

Understanding this duality is central to modern cytogenetics and human genetics. It reframes disease not as an aberration of an otherwise static genome, but as an inherent consequence of the same dynamic processes that shaped our species. By integrating molecular mechanisms, evolutionary theory, and three-dimensional genome biology, researchers and clinicians can better predict the consequences of structural variation, distinguishing when the genome\u2019s plasticity is a source of resilience\u2014and when it becomes a source of vulnerability.<\/p>

In essence, the study of structural variants bridges the evolutionary and medical dimensions of genetics. It demonstrates that the forces driving the birth of new genes, adaptive traits, and complex regulatory systems are inseparable from those that give rise to human disorders. The genome, ever dynamic, evolves and errs through the same molecular grammar\u2014a grammar that cytogenetics now seeks not only to decode, but to interpret in the context of both our past and our pathology.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tFAQ<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t1. What exactly qualifies as a structural variant (SV)?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

A structural variant is any genomic alteration larger than roughly 50 base pairs that changes the structure or organization of the DNA. This includes deletions, duplications, insertions, inversions, and translocations. Some definitions extend to complex rearrangements involving multiple breakpoints or combined events.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2. How are structural variants different from single nucleotide variants (SNVs)?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

SNVs affect one or a few bases, while SVs involve breaks and rearrangements in the DNA backbone, often spanning thousands to millions of base pairs. SVs therefore tend to have much larger effects on gene dosage, chromatin organization, and genome architecture.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t3. What are the main molecular mechanisms that generate structural variants?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

The principal mechanisms are:<\/p>